| 2,668 | 33 | 66 |
| 下载次数 | 被引频次 | 阅读次数 |
肺纤维化(Pulmonary fibrosis, PF)是呼吸系统疾病中一类极为复杂难治的疾病，PF患者诊断后生存期极短，死亡率高，故被称为“类肿瘤疾病”,严重危害着人类健康。临床上常用的抗肺纤维化的药物主要有糖皮质激素、吡非尼酮、尼达尼布、N-乙酰半胱氨酸、等，但这些药物皆存在不良反应多、价格昂贵、疗效欠佳等诸多弊端。研究发现PF的病理过程十分复杂，涉及多种机制，但其确切机制尚不明确。因此，阐明其潜在机制，提出安全有效的靶向治疗策略，是目前临床上治疗PF亟待解决的问题。大量研究证实TGF-β1/Smad信号通路在肺纤维化的发展中发挥至关重要的作用。中医药在防治肺纤维化方面具有独特优势和良好前景，其中有不少中药或中药复方可靶向调节TGF-β1/Smad信号通路。本文就TGF-β1/Smad信号传导通路在肺组织纤维化中的调控作用以及近7年来中医药靶向调控TGF-β1/Smad信号传导通路防治肺纤维化研究进展作简要综述，以期为临床中医药防治肺纤维化提供理论支撑。
Abstract：Pulmonary fibrosis(PF) is a complex and refractory respiratory disease. After diagnosis, PF patients have short survival time and high mortality, and thus PF is called a "tumor-like disease",which seriously endangers human health. The commonly used anti-PF drugs mainly include glucocorticoid, pirfenidone, nintedanib and N-acetylcysteine, but these drugs have many disadvantages such as various adverse reactions, high cost and poor efficacy. It has been found that the pathological process of PF is complicated and involves multiple mechanisms, but the exact mechanism remains unclear. Therefore, elucidating the potential mechanism of PF and proposing safe and effective targeted therapies are urgent problems to be solved in clinical treatment of PF. A large number of studies have confirmed that TGF-β1/Smad signaling pathway plays a crucial role in the development of PF. Traditional Chinese medicine(TCM) has unique advantages and good prospects in the prevention and treatment of PF,among which many single TCMs and their effective ingredients or TCM compounds can regulate TGF-β1/Smad signaling pathway in a targeted way. In this paper, the regulatory role of TGF-β1/Smad signaling pathway in PF and the research progress of TCM prevention and treatment of PF via targeting TGF-β1/Smad signaling pathway in recent 7 years were reviewed, to provide theoretical support for clinical prevention and treatment of PF by TCM.
[1]Meyer K C.Pulmonary fibrosis,part I:epidemiology,pathogenesis,and diagnosis[J].Expert Rev Respir Med,2017,11(5):343-359.
[2]Raghu G,Remy-Jardin M,Richeldi L,et al.Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults:An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.Am J Respir Crit Care Med,2022,205(9):e18-e47.
[3]黄慧，徐作军.国际特发性肺纤维化指南及进展性肺纤维化临床诊疗指南摘译[J].中华结核和呼吸杂志，2022,45(7):721-724.
[4]NIE Y,ZHANG D,QIAN F,et al.Corrigendum to "Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppressing TGF-β1 production and TGF-β1-induced fibroblasts differentiation" [Int Immunopharmacol.74 (2019) 105696].Int Immunopharmacol,2022,104:108496.
[5]Morikawa M,Derynck R,Miyazono K.TGF-β and the TGF-β Family:Context-Dependent Roles in Cell and Tissue Physiology.Cold Spring Harb Perspect Biol,2016,8(5):a021873.
[6]Saito A,Horie M,Nagase T.TGF-β Signaling in Lung Health and Disease.Int J Mol Sci,2018,19(8):2460.
[7]LUO K.Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.Cold Spring Harb Perspect Biol,2017,9(1):a022137.
[8]HU H H,CHEN D Q,WANG Y N,et al.Vaziri ND,Zhao YY.New insights into TGF-β/Smad signaling in tissue fibrosis.Chem Biol Interact,2018,292:76-83.
[9]XU F,LIU C,ZHOU D,et al.TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.J Histochem Cytochem,2016,64(3):157-167.
[10]邵松军，方海燕，叶贤伟，等.TGFβ1/Smad3信号通路介导的赖氨酸羟化酶2活性变化在肺纤维化胶原沉积中的作用[J].中国病理生理杂志，2019,35(10):1858-1863.
[11]Lodyga M,Hinz B.TGF-β1 - A truly transforming growth factor in fibrosis and immunity.Semin Cell Dev Biol,2020,101:123-139.
[12]MA T T,MENG X M.TGF-β/Smad and Renal Fibrosis.Adv Exp Med Biol,2019,1165:347-364.
[13]杨华，张莉莉.Fstl1-TGF-β1-Smad2/3信号通路与肺纤维化的靶向治疗[J].实用医药杂志，2019,36(6):562-566.
[14]KANG H.Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis.Int J Mol Sci,2017,18(12):2527.
[15]Lucarini L,Durante M,Lanzi C,et al.HYDAMTIQ,a selective PARP-1 inhibitor,improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.J Cell Mol Med,2017,21(2):324-335.
[16]FANG L,CHEN H,KONG R,et al.Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.Life Sci,2020,260:118399.
[17]LI N,FENG F,WU K,et al.Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.Biomed Pharmacother,2019,119:109387.
[18]PAN X,LI J,TU X,et al.Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.Pharmacol Res,2020,152:104592.
[19]Sriram N,Kalayarasan S,Manikandan R,et al.Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling.Clin Exp Pharmacol Physiol,2015,42(8):849-859.
[20]Ghafouri-Fard S,Abak A,Talebi SF,et al.Role of miRNA and lncRNAs in organ fibrosis and aging.Biomed Pharmacother,2021,143:112132.
[21]ZHANG S,CHEN H,YUE D,et al.Long non-coding RNAs:Promising new targets in pulmonary fibrosis.J Gene Med,2021,23(3):e3318.
[22]徐文豪，李万成.MicroRNAs在特发性肺纤维化中的作用研究进展[J].吉林医学，2022,43(4):1083-1086.
[23]SONG X,XU P,MENG C,et al.lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1.Mol Ther,2019,7(2):380-393.
[24]QIAN W,CAI X,QIAN Q.Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition.Aging (Albany NY),2020,12(5):4322-4336.
[25]朱德伟，余群，沈云辉.非编码RNA介导肺纤维化的EMT进程及天然药物干预的研究进展[J].药学学报，2021,56(11):2934-2942.
[26]HUANG C,XIAO X,YANG Y,et al.Blackburn MR,Henke CA,Liu L.MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.J Biol Chem,2017,292(40):16420-16439.
[27]ZHANG Q,YE H,XIANG F,et al.miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.Mol Ther,2017,25(3):728-738.
[28]程俊敏，吴霞，朱金月，等.从中医“肺痹、肺痿”来探析结缔组织病相关肺间质纤维化[J].时珍国医国药，2020,31(3):668-669.
[29]李芊芊，张伟.痿痹兼顾论治肺间质纤维化探讨[J].南京中医药大学学报，2018,34(3):245-247.
[30]郑钰，吕晓东，庞立健，等.特发性肺纤维化肺虚络瘀证病证结合生物标志物[J].中华中医药杂志，2019,34(4):1314-1317.
[31]刘妍彤，吕晓东，庞立健，等.“肺虚络瘀”病机观与细胞自噬在特发性肺纤维化发病过程中相关性探讨[J].中华中医药杂志，2021,36(11):6437-6440.
[32]徐昌君，王鹏飞，黄雅薇，等.黄芪总黄酮对特发性肺纤维化miRNA-21、let-7 d及TGF-β/smad信号干预作用[J].中华中医药学刊，2018,36(6):1308-1311.
[33]朱茜文，安海燕，张亚平.黄芪多糖通过调控TGF-β1/Smads信号通路对百草枯诱导的大鼠肺纤维化的影响[J].西安交通大学学报(医学版),2020,41(4):617-623.
[34]邵笑，祝骥，赵峻峰，等.丹参酮ⅡA对大鼠肺纤维化细胞TGF-β1/Smads信号通路的影响[J].浙江中西医结合杂志，2016,26(5):414-417.
[35]秦静，赵铭山，李君.丹参素干预对肺纤维化大鼠TGF-β_1/Smads信号通路的影响[J].中国病理生理杂志，2013,29(5):937-940,946.
[36]JI Y,DOU YN,ZHAO QW,et al.Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.Acta Pharmacol Sin,2016,37(6):794-804.
[37]皮娜，何琴，钟燕，等.滇龙胆草调控TGF-β1/Smad2/3信号通路抑制肺纤维化小鼠肺上皮间质转化[J].中药药理与临床，2021,37(6):58-63.
[38]付钰，吴瑕，陈随清.甘草查尔酮A通过调节TGF-β/Smad信号通路抑制小鼠肺纤维化[J].中国实验方剂学杂志，2019,25(4):94-100.
[39]CUI Y,XIN H,TAO Y,et al.Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway.Phytother Res,2021,35(2):974-986.
[40]屈艳，张崇，贾岩龙，等.大黄酸通过抑制miR-21而干预TGF-β1/Smad通路并减轻博莱霉素所致大鼠肺纤维化[J].中国病理生理杂志，2017,33(1):149-153.
[41]吴晓东，徐胜梅，杨智华，等.穿山龙总皂苷通过TGF-β/Smad信号通路减轻类风湿关节炎相关间质性肺病的肺纤维化[J/OL].中华中医药学刊：1-12[2022-11-29].
[42]刘炜，骆新，沈静.补肺汤通过TGF-β/Smad3信号通路抑制小鼠肺纤维化的研究[J].医药导报，2020,39(6):747-752.
[43]安方玉，颜春鲁，刘永琦，等.泻肺汤对肺纤维化大鼠TGF-β1/Smads信号转导通路的干预研究[J].中华中医药杂志，2018,33(6):2641-2645.
[44]MENG L,ZHANG X,WANG H,et al.Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition.Evid Based Complement Alternat Med,2019,2019:2710509.
[45]刘晓，于文涛，靳贺超，等.补肾通络方对肺纤维化大鼠肺组织TGF-β_1/Smads通路的影响[J].中国实验方剂学杂志，2019,25(2):96-102.
[46]范锐，张伟，阎小燕.补阳还五汤中黄芪不同剂量对肺纤维化大鼠TGF-β1、VEGF、PEDF等的影响[J].时珍国医国药，2022,33(3):537-541.
[47]李晓明，李作盐，石坷，等.补阳还五汤抑制大鼠肺纤维化及对肺组织TGF-β/Smads信号通路的影响[J].山东医药，2021,61(5):36-39.
[48]彭艳芳，赵映前，张莹雯，等.芪归方通过抑制miR-21而干预TGF-β1/Smad通路并减轻博莱霉素所致大鼠肺纤维化[J].时珍国医国药，2018,29(9):2112-2116.
[49]吴丽娟，何晓艳，梁静涛，等.大黄庶虫虫丸经p38 MAPK/NF-κB/TGF-β_1通路抑制小鼠硅肺纤维化的机制探讨[J].中国实验方剂学杂志，2021,27(11):27-34.
[50]蔡松，蒋锋利，黄茂，等.大黄庶虫虫丸对博来霉素致肺纤维化大鼠TGF-β1/Smad3信号通路的影响[J].环球中医药，2020,13(10):1667-1672.
[51]王杰鹏，王少贤，方倩，等.遹肺饮及其拆方对博莱霉素致肺纤维化大鼠TGF-β1/Smads信号通路的影响[J].中华中医药杂志，2019,34(11):5400-5403.
[52]张丽萍，樊香，郝莉，等.瓜蒌薤白汤对肺纤维化早期阶段肺组织中TGF-β、Smad3、Smad7表达的影响[J].中医学报，2017,32(11):2064-2069.
[53]张旭辉，刘喜平，孙杰，等.升陷汤对肺纤维化大鼠肺组织α-平滑肌肌动蛋白、肺表面活性蛋白D及TGF-β1/Smads通路蛋白表达的影响[J].中国中医药信息杂志，2021,28(4):63-68.
[54]张秀，胡静，覃惠，等.宣肺化瘀方对肺纤维化大鼠肺组织TGF-β1/Smad表达的影响[J].中草药，2018,49(14):3326-3333.
[55]钟靖.吡非尼酮抑制TGF-β1/Smad2/3通路缓解博莱霉素诱导的小鼠肺纤维化的实验研究[D].杭州师范大学，2021.
[56]周静，王璞，付向倩，等.EL-7013促进Sirt1调控TGF-β_1/Smad3通路抑制肺纤维化[J].重庆医科大学学报，2020,45(6):754-763.
[57]刘理静，钱红，尹辉明，等.硫化氢通过抑制TGF-β1/Smad信号通路抗大鼠肺纤维化[J].免疫学杂志，2015,31(12):1036-1041.
[58]谢健龙，区泳芳，陈永华，等.MiR-23b通过调节TGF-β1/SMAD3信号通路对博莱霉素所致大鼠肺纤维化及自噬水平的影响[J].临床与病理杂志，2022,42(6):1263-1274.
[59]周滟如，庞昶，陈思露，等.多西环素通过TGF-β1/Smad通路抑制百草枯诱导的肺纤维化研究[J].中华劳动卫生职业病杂志，2019,(5):337-341.
[60]马远东，黄祖伟，安培，等.盐酸氨溴索治疗大鼠肺纤维化的作用研究及其对TGF-β/Smad/ERK信号转导通路和Th17/Treg细胞失衡的影响[J].中国临床药理学与治疗学，2018,23(11):1201-1208.
基本信息:
DOI：10.13412/j.cnki.zyyl.20230220.001
中图分类号:R285.5
引用信息:
[1]李红梅,张旭辉,武妍琳,等.TGF-β1/Smad信号通路在肺纤维化中的作用及中医药调控研究进展[J].中药药理与临床,2024,40(01):123-128.DOI:10.13412/j.cnki.zyyl.20230220.001.
基金信息:
国家自然科学基金项目(编号：82260889); 甘肃省自然科学基金项目(编号：20JR5RA165); 兰州市城关区科技计划项目(编号：2021SHFZ0026)
2023-02-21
2023-02-21
2023-02-21